StemCell Institute's total assets for Q4 2024 were ¥7.50B, an increase of 4.47% from the previous quarter. JP:7096 total liabilities were ¥4.87B for the fiscal quarter, a 8.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.